The same trend was observed with the frequency of CD8+ lymphocytes, which was 26% in our study (within the values found for cancer patients, which varied from 13 to 31%), but was not markedly different from the values found for healthy dogs, which varied between 20 and 26% in other studies (27–30). The gene discussed is CD8A; the disease is cancer.